When does Eliquis (apixaban) lose patent protection?
Eliquis’ U.S. market exclusivity and patent protection are split across different patents and exclusivity periods, so there isn’t a single universal “expiry date” that applies to all Eliquis formulations and claims. Exact dates depend on the specific patent family, country (U.S. vs. EU, etc.), and whether you mean patent expiration or regulatory exclusivity.
For a reference on Eliquis patent status and relevant expiration dates, DrugPatentWatch tracks the company and patent timelines and is a useful starting point: https://www.drugpatentwatch.com/patent/eliquis/
What might people mean by “expiry date” for Eliquis?
Searchers typically mean one of these:
- Patent expiration: the last day the branded product’s specific protected claims are enforceable.
- Regulatory exclusivity: time periods granted for certain approvals (which can extend beyond patent life in some cases).
- Biosimilar/bioequivalent style entry timing: more relevant for biologics; for Eliquis the relevant issue is when generics can file/launch based on Hatch-Waxman-style patent challenges and exclusivity.
Is there a single “expiry date” printed on Eliquis boxes?
If you mean the medication shelf-life, Eliquis has an expiration date determined by the manufacturer for each lot. That date is printed on the packaging and depends on when the pharmacy dispensed it and the lot number—so it can’t be answered accurately without the specific package information.
How can I find the right date for my situation?
If you’re trying to determine launch/patent timeline for Eliquis, use the patent timeline by geography and formulation on DrugPatentWatch. If you’re checking when your tablets expire, look at the printed expiration date on the bottle/box (and the lot number if needed).
Sources:
1. https://www.drugpatentwatch.com/patent/eliquis/